Global Endometriosis Market Report 2023: Featuring Teva, Sun Pharmaceutical, Sanofi, AbbVie, AstraZeneca, Pfizer & More
March 15, 2023 06:28 ET
|
Research and Markets
Dublin, March 15, 2023 (GLOBE NEWSWIRE) -- The "Global Endometriosis Market Size, Share & Industry Trends Analysis Report By Type, By Treatment (Oral Contraceptives, Gonadotropin-releasing...
Global Gynecology Partnering Analysis Report 2022: Access Deals and Contract Documents for 490+ Gynecology Deals
September 05, 2022 07:28 ET
|
Research and Markets
Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "Global Gynecology Partnering 2010-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.The Global...
Ananda Professional is Opening Enrollment to Participate in an IRB-Approved Phase IV Clinical Trial Investigating How CBD May Benefit Women's Health and Wellness
March 07, 2022 13:00 ET
|
Ananda Professional
GEORGETOWN, Ky., March 07, 2022 (GLOBE NEWSWIRE) -- Ananda Professional has committed $40 million to advance the clinical evidence of hemp extract through clinical research. As part of this...
Endometriosis Market Spotlight Report 2021: Bayer Leads Industry Sponsors with the Highest Overall Number of Clinical Trials, Followed by AbbVie and Takeda
February 03, 2022 05:03 ET
|
Research and Markets
Dublin, Feb. 03, 2022 (GLOBE NEWSWIRE) -- The "Market Spotlight: Endometriosis" report has been added to ResearchAndMarkets.com's offering. Endometriosis is an estrogen-dependent condition that...
Worldwide Women's Health Industry to 2026 - Key Drivers and Restraints
January 20, 2022 05:08 ET
|
Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "Therapeutics for Women's Health: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This report is an...
Global Gynecology Partnering 2010 to 2021: Deal Trends, Players and Financials
December 23, 2021 04:43 ET
|
Research and Markets
Dublin, Dec. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Gynecology Partnering 2010-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. Global...
Global $13.34 Bn Gynecology Drugs Markets, Competition, Forecasts & Opportunities, 2026
August 23, 2021 06:13 ET
|
Research and Markets
Dublin, Aug. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Gynecology Drugs Market, By Therapeutics (Hormonal Therapy vs. Non-Hormonal Therapy), By Indication, By Distribution Channel, By Region,...
Global Non-hormonal Therapies for Women's Health Market Report 2021-2030: Current Market Landscape with Focus on Prescription Drugs & Future Potential of this Evolving Market
July 20, 2021 04:18 ET
|
Research and Markets
Dublin, July 20, 2021 (GLOBE NEWSWIRE) -- The "Non-hormonal Therapies for Women's Health Market by Target Indication, Type of Molecule, Purpose of Therapy, Mechanism of Action, Route of...
ObsEva Announces Enrollment Completion of Linzagolix Phase 3 EDELWEISS 3 Trial for Patients with Moderate to Severe Endometriosis-Associated Pain
May 04, 2021 01:00 ET
|
ObsEva SA
- EDELWEISS 3 trial of Yselty® expected to report topline data as planned in Q4:21- GENEVA, Switzerland and BOSTON, MA – May 4, 2021 – ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a...
Predictive Laboratories Launches FertilityDX™
October 14, 2019 08:00 ET
|
Predictive Technology Group, Inc.
SALT LAKE CITY, Oct. 14, 2019 (GLOBE NEWSWIRE) -- Predictive Laboratories, a wholly owned molecular and genetic diagnostics company of Predictive Technology Group (OTC Pink: PRED) focused on...